CLINICAL
TRIALS
Clinical Trials Concerning Implantable Port
| Phase II Study of Hepatic Arterial Infusion Chemotherapy with Fluorouracil for Metastatic Unresectable Colorectal Cancers of the Liver (JFMTC-28) (Japan) | Protocol (Japanese) |
| Phase III Randomized Study of Inrahepatic Arterial vs Intravenous Infusion of Fluorouracil After Surgery for Patients with Metastatic Colorectal Cancer of the Liver (JFMTC-29) (Japan) | Protocol (Japanese) |
| A Phase II Study of Isolated Hepatic Perfusion (IHP) with Melphalan Followed by Postoperative Hepatic Arterial Infusion Chemotherapy for Metastatic Unresectable Colorectal Cancers of the Liver (NCI-99-C-0093) (U.S.A.) | Protocol |
| Combination Chemotherapy After Surgery in Treating Patients With Liver Metastases From Colorectal Cancer (MSKCC-98072, NCI-H99-0024) (U.S.A.) | Protocol |
| Phase I Study of Hepatic Intra-Arterial Floxuridine and Dexamethasone With Intravenous Oxaliplatin, Fluorouracil, and Leucovorin Calcium With or Without Cryosurgery in Patients With Unresectable Hepatic Metastases from Colorectal Cancer (MSKCC-00009, NCI-G00-1896) (U.S.A.) | Protocol |
| Phase II Study of Isolated Hepatic Perfusion with Melphalan in Patients with Primary Unresectable Liver Cancer or Metastases to the Liver (NCI-99-C-0123) (U.S.A.) | Protocol |
| Phase II Study of Radiofrequency Interstitial Ablation Followed By Hepatic Arterial Chemotherapy With Floxuridine and Fluorouracil in Patients With Colorectal Metastatic to the Liver (MDA-ID-98035, NCI-G97-1616) (U.S.A.) | Protocol |
| Phase III Randomized Study of Hepatic Artery FUDR/ CF/ DM vs Systemic 5-FU/ CF for Hepatic Metastases From Colorectal Cancer (CLB-9481) (U.S.A.) | Protocol |
| Phase III Randomized Study of Intravenous vs Intrahepatic Arterial Infusion of 5-FU/ CF for Colorectal Cancer Metastatic to the Liver (MRC-CR05, EU-95032) (U.K..) | Protocol |
| Phase III Randomized Study of Regional and Systemic Chemotherapy With or Without Isolated Hepatic Perfusion With Melphalan in Patients With Unresectable Colorectal Cancer Metastatic to the Liver (NCI-01-C-0093) (U.S.A.) | Protocol |